PrintyMed
PrivateLast Round
Grant
Apr 28, 2026
Total Funding Raised
$1.62M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
PrintyMed operates in Healthcare & Life Sciences and is based in Riga. Its latest recorded funding round was a Grant round in April 2026.
PrintyMed is a biotechnology company that develops biomimetic spider silk materials for use in regenerative medicine and 3D-printed artificial organs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Advanced Materials, 3D Printing
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PrintyMed Comparables
Compare PrintyMed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spiber Technologies AB | 84% | |
| Seevix Material Sciences | 80% | |
| Cellbox Labs | 74% |
For institutional investors. Book with your work email.
PrintyMed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 28, 2026 | ||||
| Grant | Mar 5, 2026 | ||||
| Accelerator | Sep 23, 2025 | ||||
| Grant | Oct 8, 2024 | ||||
| Grant | Dec 11, 2023 | ||||
Pre Seed | Aug 28, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PrintyMed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Confluence | Accelerator |
| Investment and Development Agency of Latvia | Grant, Accelerator |
| Health Founders | Pre Seed |
| Women TechEU | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 5, 2026
$86K grant received from Women TechEU
- Sep 23, 2025
$6K round from Confluence, Helve, and Investment and Development Agency of Latvia.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingAug 6, 2026
PrintyMed secures about €2 million in grants, including $87K from Women TechEU and roughly €700,000 through a European Innovation Council programme, supporting its expertise in regulation, intellectual property, scaling, and fundraising.
For institutional investors. Book with your work email.
PrintyMed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PrintyMed's valuation, stock price, and market status.
Is PrintyMed a public or private company?
PrintyMed is a private company.
What is the current stock price of PrintyMed?
PrintyMed is a private company, so its shares have no public market price. Caplight tracks PrintyMed's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PrintyMed worth (valuation)?
Valuation information for PrintyMed is not publicly available.
Can I buy PrintyMed stock?
PrintyMed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PrintyMed's last funding round?
PrintyMed's most recent funding round was Grant on April 28, 2026.
Who are the main investors in PrintyMed?
Key investors in PrintyMed include European Innovation Council Fund, Confluence, Investment and Development Agency of Latvia, Health Founders, Women TechEU.
Will PrintyMed IPO soon?
No public IPO plans have been announced for PrintyMed.
How can I track PrintyMed secondary market activity?
Caplight tracks bids, offers, and trades in PrintyMed's shares on secondary markets.